Pricing
  1. JP-listed companies
  2. Qol Holdings Co.,Ltd.
  3. Financials
  4. EBITDA

Qol Holdings Co.,Ltd.【JP:3034】

Market cap
¥68.8B
P/E ratio
9.5x
Cure All Holdings operates pharmacies, provides business outsourcing services to pharmaceutical companies, and manufactures drugs to support healthcare across communities.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 202517,496+72.00%
Mar 31, 202410,172-8.98%
Mar 31, 202311,175-2.15%
Mar 31, 202211,420+27.68%
Mar 31, 20218,944-4.67%
Mar 31, 20209,382+7.00%
Mar 31, 20198,768-18.17%
Mar 31, 201810,715+26.82%
Mar 31, 20178,449+1.60%
Mar 31, 20168,316+42.06%
Mar 31, 20155,854

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)